NASDAQ · XAIRHealthcareSurgical Instruments

Beyond Air financials

$2.83+9.27%
Close Sep 29, 2026 · split-adjusted

Revenue

Net income

Income statement & cash flow

Fiscal yearFY26
Mar 31
FY25
Mar 31
FY24
Mar 31
FY23
Mar 31
FY22
Mar 31
FY21
Mar 31
FY20
Mar 31
Revenue$7.7M$3.7M$1.2M$0.00$0.00$873.0K$1.4M
Gross profit$252.0K-$1.7M-$1.3M-$555.0K$0.00$873.0K$1.4M
Gross margin3.3%−44.9%−112.8%——100.0%100.0%
Operating income-$29.0M-$44.5M-$63.0M-$52.1M-$40.7M-$22.2M-$18.1M
Net income-$33.2M-$46.6M-$60.2M-$55.8M-$43.2M-$22.9M-$20.5M
Net margin−433.0%−1258.4%−5197.8%——−2620.3%−1472.2%
Diluted EPS$-80.20$-275.40$-728.00$-744.00$-672.00$-508.00$-712.00
EBITDA-$25.8M-$41.3M-$61.0M-$51.2M-$40.1M-$22.0M-$18.0M
Operating cash flow-$18.1M-$38.2M-$56.0M-$33.0M-$23.1M-$19.6M-$15.3M
Free cash flow-$19.2M-$44.1M-$61.8M-$36.9M-$24.5M-$20.5M-$15.3M
Diluted shares0.4M0.2M0.1M0.1M0.1M0.0M0.0M

Balance sheet

Period endMar 31Mar 31Mar 31Mar 31Mar 31Mar 31
Cash & equivalents$6.7M$4.7M$11.4M$29.2M$80.2M$34.6M
Short-term investments$4.9M$2.3M$23.1M$16.7M$0.00—
Total debt$22.0M$9.8M$15.5M$895.0K$9.1M$5.0M
Total assets$35.4M$30.1M$57.0M$68.7M$99.2M$40.5M
Total liabilities$29.2M$15.7M$29.8M$26.7M$21.0M$10.1M
Shareholders' equity$6.2M$14.3M$27.2M$42.0M$78.2M$30.5M

From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology